FDA Approves Revolutionary Sickle Cell Gene Therapy, Marking a Major Breakthrough
The FDA has approved a groundbreaking gene therapy treatment for sickle cell disease, a chronic condition that affects thousands of Americans, particularly those with African ancestry. The treatment utilizes the gene-editing tool CRISPR and is seen as a significant development in the field of medicine.